BioSuspensions Limited was formed in 2008, to exploit a novel structured suspension technology.
The company's SpheruliTEK™ technology allows insoluble drugs to be presented in a liquid formulation in much higher concentrations than has been previously possible, with greater flexibility in terms of particle size, complexity and range, lower viscosity and higher stability.
BioSuspensions was formed by BioStatus Limited, who have funded all of the company's research and development to date. More details about BioStatus can be found at biostatus.com
BioSuspensions is a company registered in England and Wales, reg no: 06780280
For further information please contact: email@example.com